Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 3/2016

01-03-2016 | Original Article

Sexual function, depression, and quality of life in patients with cervical cancer

Authors: Hyewoo Bae, Hyojung Park

Published in: Supportive Care in Cancer | Issue 3/2016

Login to get access

Abstract

Purpose

The purpose of this study was to examine the level of sexual function, depression, and quality of life in cervical cancer patients.

Methods

This descriptive, correlational, cross-sectional study was conducted at E Hospital, Seoul. A total of 137 women diagnosed with cervical cancer completed a structured questionnaire. Sexual function was measured with the Female Sexual Function Index (FSFI), depression with the Hospital Anxiety and Depression Scale (HADS), and quality of life with the Functional Assessment of Cancer Therapy–General version 4 (FACT-G). Descriptive statistics, ANOVA, Scheffé’s tests, and Pearson correlations were computed with SPSS Win 21.0.

Results

The participants experienced sexual dysfunction (4.83 ± 4.16) and moderate to severe depression (11.08 ± 5.06). The mean score of quality of life was 57.33 ± 8.47. Sexual function had a negative relationship with depression, while having a positive one with quality of life (p < .001). Also, in relation with subcategories of quality of life, sexual function was positively correlated with physical well-being, social well-being, and functional well-being (p = .001), but not with psychological well-being (p = .223).

Conclusion

This study showed that cervical cancer patients with lower sexual function tended to have lower quality of life and higher levels of depression. Thus, clinical nurses should develop and implement interventions to enhance sexual function for patients diagnosed with cervical cancer.
Literature
1.
2.
3.
4.
Byun J, Lee J, Park J, Kim Y, Lee E, Chang K, Ryu H (2006) Factors influencing quality of life of cervical cancer patients in Korea. Obstet Gynecol Sci 49:2363–2572
5.
Nesrin R, Nezihe B, Anahit C (2010) Quality of life and sexual functioning in gynecological cancer patients: results from quantitative and qualitative data. Eur J Oncol Nurs 14:137–146CrossRef
6.
Vicki C, Josephine H, Geraldine M (2011) Sexuality in Irish women with gynecologic cancer. Oncol Nurs Forum 38:87–96CrossRef
7.
Kristen A, Kritine K (2012) A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecol Oncol 124:477–489CrossRef
8.
Mariagrazia D, Silvia R, Giovanni C, Barbara C, Marco P, Caterina R, Giovanni S, Gabriella F (2008) Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy. Gynecol Oncol 111:144–150CrossRef
9.
Alex M, Melissa C, Henna B, Marie H, Luigi G, Christoffer J, Nicholas M (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative care settings: a meta analysis of 94 interview based studies. Lancet Oncol 12:160–174CrossRef
10.
Yi-Long Y, Li Liu Y, Hui W, Xiao-Shi Y, Jia-na W, Lei W (2013) The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis. BMC Cancer 13:393CrossRef
11.
Kathryn T (2008) Sexuality: a quality of life issue for cancer survivors. Semin Oncol Nurs 24:71–79CrossRef
12.
13.
Rosen R, Brown C, Heiman J et al (2000) The Female Sexual Function Index (FSFI): a multidimensional self-reported instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208CrossRefPubMed
14.
Kim H, So H, Park K et al (2002) Development of the Korean version of Female Sexual Function Index (FSFI). Kor J Androl 20:50–56
15.
Zigmond AS, Snaith PR (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed
16.
Cella D, Tulsky D, Gray G, Sarafian B, Linn E, Bonomi A et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed
17.
Chun N, Park Y (2006) Sexual functioning in women with gynecologic cancer. Kor J Women Health Nurs 12:308–315
18.
Chun N (2010) Predictors of sexual desire, arousal, lubrication, orgasm, satisfaction, and pain in women with gynecologic cancer. J Korean Acad Nurs 40:24–32CrossRefPubMed
19.
Park J, Jang S (2012) A study on the predictive factors of sexual function in women with gynecologic cancer. Asian Oncol Nurs 12:156–165CrossRef
20.
Kobayashi M, Ohno T, Noguchi W, Matsuda A, Matsushima E, Kato S, Tsujii H (2009) Psychological distress and quality of life in cervical cancer survivors after radiotherapy: do treatment modalities, disease stage, and self-esteem influence outcomes. Int J Gynecol Cancer 19:1264–1268CrossRefPubMed
21.
Jeong J, So H, Hong J, Chae M, Han G (2012) Related factors to quality of life among hospitalized cancer patients undergoing chemotherapy. Asian Oncol Nurs 12:84–91CrossRef
22.
Lee J, Choi S (2007) Quality of life in gynecological cancer patients during chemotherapy. Kor J women Health Nurs 13:290–298
23.
Ruth M, Siew T, Howard G, Gwynne H, Mary L (2006) Factors related to depressive symptoms among long-term survivors of cervical cancer. Health Care Women Int 27:45–58CrossRef
Metadata
Title
Sexual function, depression, and quality of life in patients with cervical cancer
Authors
Hyewoo Bae
Hyojung Park
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 3/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2918-z

Other articles of this Issue 3/2016

Supportive Care in Cancer 3/2016 Go to the issue

Original Article

Patient housing barriers to hematopoietic cell transplantation: results from a mixed-methods study of transplant center social workers

Original Article

Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial

Original Article

Presentation patterns and outcomes of patients with cancer accessing care in emergency departments in Victoria, Australia

Original Article

Venous access: the patient experience

Original Article

An online self-care education program to support patients after total laryngectomy: feasibility and satisfaction

Original Article

Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits